Thyroid hormone modulates insulin-like growth factor-i (IGF-I) and IGF- binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases

Hormone and Metabolic Research

Volumn 31, Issue 10, 1999, Pages 576-579

  Inukai, Toshihiko ^a,b   Takanashi, K ^a   Takebayashi, K ^a   Fujiwara, Y ^a   Tayama, K ^a   Takemura, Y ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Dokkyo Medical University   (Japan)

Author keywords

GH; Graves' Disease; Hashimoto's Thyroiditis; IGF I; IGFBP 3

Indexed keywords

GROWTH HORMONE; LEVOTHYROXINE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THIAMAZOLE; THYROID HORMONE; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HASHIMOTO DISEASE; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THYROID DISEASE;

EID: 0032720637     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978798     Document Type: Article

References (22)

1. Albiston AL, Saffery R, Herington AC. Cloning and characterization of the promoter for the rat insulin-like growth factor-binding protein-3-gene. Endocrinology 1995; 136: 696-704
2. Sugisaki T, Yamada T, Takamatsu K, Noguchi T. The influence of endocrine factors on the serum concentrations of insulin-like growth factor-I (IGF-I) and IGF-binding proteins. J Endocrinol 1993; 138: 467-477
3. Nanto-Salonen K, Mullar HL, Hoffman AR, Vu TH, Rosenfeld RG. Mechanism of thyroid hormone action on the insulin-like growth factor system. All thyroid hormone effects are not growth hormone mediated. Endocrinology 1993; 132: 781-788
4. Rodriguez-Arnao J, Miell J, Thomas M, McGregor AM, Ross RJM. Changes in hepatic insulin-like growth factor-binding protein-1, -2 and -3 mRNA levels in rats with altered thyroid status. J Endocrinol 1994; 140: 251-255
5. Frystyk J, Gronbaek H, Skjaerbaek C, Flyvbjerg A. Effect of hyperthyroidism on circulating levels of free and total IGF-I and IGFBPs in rats. Am J Physiol 1995; 269: E840-E845
6. Nanto-Salonen K, Rosenfeld RG. Insulin-like growth factor binding protein expression in the hypothyroid rat is age dependent. Endocrinology 1992; 131: 1489-1496
7. Wang JF, Becks GP, Hanada E, Buckingham KD, Phillips ID, Hill DJ. Hormonal regulation of insulin-like growth factor (IGF)-binding proteins secreted by isolated sheep thyroid epithelial cells: relationship with iodine organification. J Endocrinol 1993; 138: 467-477
8. Eggo MC, Sheppard MC. Autocrine growth factors produced in the thyroid. Mol Cell Endocrinol 1994; 100: 97-102
9. Phillips ID, Becks GP, Wang JF, Han VKM, Hill DJ. Hormonal regulation and biological actions of insulin-like growth factor binding proteins in isolated ovine thyroid follicles. Endocrinology 1994; 134: 1238-1246
10. Nanto-Salonen K, Glasscock GF, Rosenfeld RG. The effects of thyroid hormone on insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) expression in the neonatal rat: prolonged high expression of IGFBP-2 in methimazole-induced congenital hypothyroidism. Endocrinology 1991; 129: 2563-2570
11. Angervo M, Leinonen P, Koistinen R, Julkunen M, Seppala M. Triiodothyronine and cycloheximide enhance insulin-like growth factor-binding protein-1 gene expression in human hepatoma cells. J Mol Endocrinol 1993; 10: 7-13
12. Miell JP, Taylor AM, Zini M, Maheshwari HG, Ross RJM, Valcavi R. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J Clin Endocrinol Metab 1993; 76: 950-955
13. 3 pituitary tumor cells. Endocrinology 1992; 130: 1483-1489
14. Glantschnig H, Varga F, Klaushofer K. Thyroid hormone and retinoic acid induce the synthesis of insulin-like growth factor-binding protein-4 in mouse osteoblastic cells. Endocrinology 1996; 137: 281-286
15. Wan Nazaimoon WN, Osman A, Wu LL, Khalid BAK. Effects of iodine deficiency on insulin-like growth factor I, insulin-like growth factor-bind ing protein-3 levels and height attainment in malnourished children. Clin Endocrinol 1996; 45: 79-83
16. Miell JP, Zini M, Quin JD, Jones J, Portioli I, Valcavi R. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thryoidectomy. J Clin Endocrinol Metab 1994; 79: 1507-1512
17. Angervo M, Tiihonen M, Leinonen P, Valimaki M, Seppala M. Thyroxine treatment increases circulating levels of insulin-like growth factor binding protein-1: a placebo-controlled study. Clin Endocrinol 1993; 38: 547-551
18. Wang JF, Hill DJ, Becks GP. Role of 3′,5′-cyclic adenosine monophosphate and protein kinase C in the regulation of insulin-like growth factor-binding protein secretion by thyroid-stimulating hormone in isolated ovine thyroid cells. J Endocrinol 1994; 141: 231-242
19. Eggo MC, King WJ, Black EG, Sheppard MC. Functional human thyroid cells and their insulin-like growth factor-binding proteins: regulation by thyrotropin, cyclic 3′,5′-adenosine monophosphate, and growth factors. J Clin Endocrinol Metab 1996; 81: 3056-3062
20. Angervo M, Toivonen J, Leinonen P, Valimaki M, Seppala M. Thyroxine withdrawal is accompanied by decreased circulating levels of insulin-like growth factor-binding protein-1 in thyroidectomized patients. J Clin Endocrinol Metab 1993; 76: 1199-1201
21. Vinter-Jensen L, Juhl CO, Frystyk J, Dajani EZ, Oksbjerg N, Flyvbjerg A. The effect of epidermal growth factor on circulating levels of IGF and IGF-binding proteins in adult Goettingen minipigs. J Endocrinol 1996; 151: 401-407
22. Van Der Laan B, Freeman JL, Asa SL. Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues. Thyroid 1995; 5: 67-73